|
1. Motovali-Bashi M, Hojati Z, Rezaei Z, Hemmati S. Investigation of association between genetic diversities in Yq11.223 region with men infertility in Isfahan population. J Isfahan Med Sch 2011; 142(2): 707-14. [in Persian] 2. Motovali-bashi M, Miroliaei M, Sedaghat S, Ahmadi SM. Effect of PON1 L55M polymorphism on infertility among Iranian females population. Iran J Biol 2012; 2(25): 230-9. [in Persian] 3. Ozkan S, Murk W, Arici A. Endometriosis and Infertility: Epidemiology and Evidence-based T reatments. Ann N Y Acad Sci 2008; 1127(1): 92–100. 4. Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet 2010; 27)8(: 441–7. 5. Pandey MK, Rani R, Agrawal S. An update in recurrent spontaneous abortion. Arch Gynecol Obstet 2005; 272(2): 95–108. 6. Pan Q, Luo X, Toloubeydokhti T, Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007; 13(11):797–806. 7. Pan Q, Luo X, Chegini N. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med 2008; 12(1): 227–40. 8. Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009; 285(2):116-26. 9. Kim M, Kasinski AL, Slack FJ. MicroRNA therapeutics in preclinical cancer models. Lancet Oncol 2011; 12(4): 319-21. 10. Santamaria X, Taylor H. MicroRNA and gynecological reproductive diseases. Fertil Steril 2014; 101(6): 1545–51. 11. Zheng B, Xue X, Zhao Y, Chen J, Xu Ch-Y and Duan P. The differential expression of microRNA-143/145 in endometriosis. Iran J Reprod Med 2014; 12(8): 555-60. 12. Kohan L, Zarei A, Fallahi S, Tabiee O. Association between vaspin rs2236242 gene polymorphism and polycystic ovary syndrome risk. Gene 2014; 539(2): 209-12. 13. Bulun SE. Mechanisms of disease endometriosis. N Engl J Med 2009; 360(3): 268-79. 14. Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Economic burden of endometriosis. Fertil Steril 2006; 86:1561–72. 15. Hemmings R, Rivard M, Olive DL, Poliquin-Fleury J, Gagné D, Hugo P, et al. Evaluation of risk factors associated with endometriosis. Fertil Steril 2004; 81(6): 1513–21. 16. Fassbender A, Vodolazkaia A, Saunders P, Lebovic D, Waelkens E, De Moor B, et al. Biomarkers of endometriosis. Fertil Steril 2013; 99(4): 1135–45. 17. Low WY, Edelmann RJ, Sutton C. A psychological profile of endometriosis patients in comparison to patients with pelvic pain of other origins. J Psychosom Res 1993; 37(2): 111-6. 18. ZhaoW, Zhao SP, Zhao YH. MicroRNA-143/-145 in Cardiovascular Diseases. Biomed Res Int 2015; 2015: 531740. 19. Fu X, Guo L, Jiang ZM, Zhao LS, Xu AG. An miR-143 promoter variant associated with essential hypertension. Int J Clin Exp Med 2014; 7(7):1813-7. 20. Chu H, Zhong D, Tang J, Li J, Xue Y, Tong N, et al. A functional variant in miR‑143 promoter contributes to prostate cancer risk. Arch Toxicol 2016; 90(2): 403-14. 21. Yang L, Gao X, Luo H, Huang Q, Wei Y, Zhang G, et al. No Association of Pri-miR-143 rs41291957 Polymorphism with the Risk of Congenital Heart Disease in a Chinese Population. Pediatr Cardiol 2014; 35(6): 1057-61. 22. Li L, Pan X, Li Z, Bai P, Jin H, Wang T, et al. Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer. Hum Immunol 2013; 74(8): 993-7.
|
.png){kind=logo}
